Cost is a barrier Tirzepatide is not cheap
Liver health support: May reduce fat buildup in the liver, a common complication of excess weight
Implications from the study included that 8.9% of diabetic patients and 6.7% of obese patients on GLP-1 developed NAION compared to 1.8% and 0.8% respectively in those using other medications
Additionally, GLP-1 slows gastric emptying, which prolongs the feeling of fullness, and reduces the release of glucagon, a hormone that raises blood sugar levels
CERABETA: A Superior Fiber Solution While Fiber is always important, it becomes crucial when using a weight loss medication like Ozempic or other semaglutide-based medications
6 Cleveland Clinic, GLP-1 Agonists, July 3, 2023